← Leaderboards
Tanya Christineh Petrossian
Endomet Biosciences, Inc
$5,932,914
Attributed
$7,642,550
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,642,550 · 2
By mechanism
R44$5,596,768 · 1
SB1$2,045,782 · 1
Top collaborators
- Katherine Anne Burns4 shared
Others in their field
Other Emerging Leaders on “Infertility”
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
- Scot P Ouellette · University Of Nebraska Medical Center$6,167,697
- Ismail Emre Ozkumur · Autoivf, Inc.$5,274,372
- Francesca E. Duncan · Northwestern University At Chicago$5,059,415
- Akhgar Ghassabian · New York University School Of Medicine$4,497,447
- Shuo Xiao · University Of South Carolina At Columbia$4,279,035
Research focus
InfertilityLesionHormonesHysterectomyHormonalLead CandidateDoseEthnic OriginExcisionExhibitsEndometrialGonadotropin Releasing Hormone InhibitorEndometriosisEpidemicBeta CateninClinical TrialsCellsCell NucleusAffectDisease ProgressionDisabilityDiagnosisCell Membrane PermeabilityLibraries
Grant awards (8)
Novel, Non-hormonal Therapeutic for Endometriosis$2,045,782
SB1 · FY2025 · HD · contact PI
Novel, Non-hormonal Therapeutic for Endometriosis$177,500
R44 · FY2025 · HD · contact PI
Novel, Non-hormonal Therapeutic for Endometriosis$999,998
R44 · FY2024 · HD · contact PI
Novel, Non-hormonal Therapeutic for Endometriosis$999,997
R44 · FY2023 · HD · contact PI
Novel, Non-hormonal Therapeutic for Endometriosis$1,049,997
R44 · FY2022 · HD · contact PI
Novel, Non-hormonal Therapeutic for Endometriosis$1,115,958
R44 · FY2021 · HD · contact PI
Novel, Non-hormonal Therapeutic for Endometriosis$956,480
R44 · FY2020 · HD · contact PI
Novel, Non-hormonal Therapeutic for Endometriosis$296,838
R44 · FY2019 · HD · contact PI